© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
823368 |
As an accredited 4-Bromo-3-(Trifluoromethyl)Aniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-3-(Trifluoromethyl)Aniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
4-Bromo-3-(Trifluoromethyl)Aniline, recognized among chemists by its CAS number 328-70-1, occupies a unique spot on the workbench of researchers hunting for precision and reactivity. The molecule folds together a bromine atom, a trifluoromethyl group, and an aniline core—a combination that rarely sits idle in research projects. With a molecular formula of C7H5BrF3N and a molar mass tipping the scales at about 256.03 g/mol, this compound shows up where tailored electronic features and selectivity matter more than basic utility.
Anyone spending enough time in a research lab notices patterns in molecular design. Here, every atom seems to have a reason for being. The bromine atom brings a certain heft and reactivity, making the compound a strong candidate for cross-coupling reactions like Suzuki or Buchwald-Hartwig aminations. Its ability to act as an efficient halide substrate favors carbon-nitrogen bond formation, an integral part of building pharmaceuticals and advanced materials.
The trifluoromethyl group is more than just a group of three fluorines tacked onto a carbon. This feature can transform the electronic landscape of the aromatic ring; it increases electron-withdrawing power, changing acidity, affecting hydrogen bonding, and improving metabolic resistance in final products. Chemists often go after this kind of functionality for drug candidates that need to stick around in the body long enough to do their job—or for agrochemical leads chasing selective toxicity. From my own experience in the lab, tweaking a molecule’s function by swapping in a trifluoromethyl group sometimes changes a compound’s profile more than a dozen other modifications combined.
What’s often overlooked is the interplay between the bromine and the trifluoromethyl positions on the ring. Placing bromine at the four-position and the CF3 at the three-position sets up a subtle chemical dance. This arrangement not only creates new targets for nucleophilic substitutions but also shifts the reactivity pattern of the entire molecule—a point that matters for scientists fine-tuning catalysis pathways or hunting for improved intermediates during synthesis.
Not all aromatic amines pull the same weight. The everyday aniline sets a benchmark for reactivity but rarely offers the selectivity or durability that advanced applications demand. Substituted anilines like 4-Bromo-3-(Trifluoromethyl)Aniline supply an edge, stepping up where plain structures fizzle out. Consider a baseline molecule such as para-bromoaniline or 3-trifluoromethylaniline; these each have some degree of selectivity but fall short when the task calls for balancing electronic effects with steric hindrance. When looking at halogenated or fluorinated versions, many lack either the brawn required for robust coupling reactions or the metabolic stability crucial for pharmaceutical applications.
Experience tells me that chemists often return to 4-Bromo-3-(Trifluoromethyl)Aniline in late-stage functionalization projects. The molecule’s dual substituents—bromine and CF3—cover an important range of chemical behaviors. The fluorinated group resists oxidative degradation, while the presence of bromine keeps the molecule in play for further elaboration.
Every day in the pharmaceutical world, teams chase molecules that combine reactivity and biological persistence. Substituted anilines, especially those with rugged scaffolds, serve as starting points for anti-cancer therapeutics, agrochemical actives, and imaging agents. The structure of 4-Bromo-3-(Trifluoromethyl)Aniline lets medicinal chemists attach other groups and modify leads for better target binding. In crop protection, the molecule paves the way for formulations seeking greater selectivity and reduced off-target environmental effects.
Over years of practical work, I have seen the compound shine most during lead optimization. Adding a trifluoromethyl group to an aromatic amine changes solubility, permeability, and metabolic fate in animal models. Meanwhile, bromine serves as a reliable handle for late-stage diversification. Their interaction hovers between two priorities: transforming pharmacokinetics and allowing chemists to quickly access analogs by swapping out the bromine. If you’ve tried to push an aniline further down the drug pipeline, you know how rare this combination can be.
The story of any specialty molecule follows the hands that shape it. Synthesizing 4-Bromo-3-(Trifluoromethyl)Aniline usually involves a series of precise steps: selective bromination of a trifluoromethylaniline, or the installation of a trifluoromethyl group onto a bromoaniline. Both routes produce mixtures that require patient separation—but the yield pays off, especially for research groups chasing new nitrogen-based pharmaceuticals or polymers requiring a strong electron-withdrawing scaffold.
Some producers use copper-catalyzed couplings or palladium-based cross-couplings to install bromine on an already-fluorinated aromatic ring. Each method comes with trade-offs: older bromination conditions may generate unwanted byproducts, modern fluorination can push up costs, and some steps stretch the need for purification. Still, for those invested in efficiency, route selection can make or break a project’s budget and lead time. In practice, working with a trusted synthetic strategy cuts down on bottlenecks in scale-up and makes regulatory documentation far less taxing later on.
If you’ve handled aromatic amines before, you already know the importance of a well-ventilated hood, gloves, and eye protection. Although 4-Bromo-3-(Trifluoromethyl)Aniline usually arrives as an off-white to pale yellow crystalline solid, its potential health effects should never be minimized. I recall early days as a graduate student, learning quickly how tiny droplets or dust can travel across the bench—a quick reminder that chemical respect often stands as your best defense. Standard literature indicates moderate toxicity; keeping procedures tight and documenting each step not only protects workers but ensures that batch quality stays consistent.
From a practical perspective, the melting point of roughly 68–72 degrees Celsius means you don’t have to worry about it vaporizing at room temperature, which eases some handling concerns. Still, clean storage in sealed containers prevents hydrolysis by moisture and cuts down on unwanted side reactions—a lesson spelled out in more than one disappointing NMR spectrum over the years.
The story of any special chemical really unfolds in how it gets used. Over the past decade, 4-Bromo-3-(Trifluoromethyl)Aniline found a place in multiple sectors. In pharmaceutical research labs, it shows up during the hunt for kinase inhibitors, anti-inflammatory compounds, and enzyme-modifying agents. Some major journals detail its role as a building block for central nervous system drug candidates, where the combined effects of fluorine and bromine tweak both potency and metabolic clearance.
In materials science, the compound becomes more than just a stepping stone. Reactive intermediates stemming from its structure serve as anchor points for advanced polymers, where unusual electronic effects are needed. Specialty dyes, liquid crystals, and OLED components have been known to rely on such structures for optimal performance. The electron-rich aniline and electron-poor trifluoromethyl team up to shift absorption spectra, yielding brighter colors and improved photostability—qualities that matter on display screens and specialized sensors.
Personal experience with collaboration between discovery and process chemistry teams often highlights how this molecule acts as a connector. It bridges efforts between theoretical ideas and actual bench-scale synthesis, turning paper sketches into testable real-world samples. Each team values it differently: medicinal chemists talk up its modification options; materials scientists see a gateway to new physical properties.
Relying on any specialty molecule brings challenges. Supply and cost tend to go hand in hand. Since the synthetic route for 4-Bromo-3-(Trifluoromethyl)Aniline involves precise halogenation and fluorination, fluctuations in the upstream raw materials often ripple downstream. Strong demand from pharmaceutical and chemical industries occasionally strains supply or pushes prices upward, forcing procurement teams to hunt for alternative suppliers or even rethink synthesis plans.
Lab-scale synthesis brings its own hurdles. I remember troubleshooting purification bottlenecks when a brominated product came through with stubborn trace impurities. Skilled chemists often learn tricks from experience—adjusting solvent systems, fine-tuning crystallization conditions, or employing flash chromatography. Each challenge adds up to a steeper learning curve and, at times, slower progress for early-stage research.
Disposal of fluorinated and brominated waste also requires careful attention. Chemical residues demand specialized protocols to avoid environmental damage. Many institutions now factor in end-of-life considerations for intermediates and solvents, recognizing the environmental load such specialty chemicals can impose. Investment in waste treatment infrastructure or green chemistry alternatives increasingly looks like a basic requirement, not a luxury.
Trust in the application of specialty chemicals relies on a culture of evidence and responsibility. The presence of both bromine and fluorine in 4-Bromo-3-(Trifluoromethyl)Aniline’s structure raises questions among environmental chemists and regulators alike. Persistence of fluorinated compounds in soil and water earned much attention over the last several years. Research continues into safer alternatives and degradable analogs, but for now, the molecule’s unique properties deliver value where no easy substitutes exist.
Transparency on sourcing and purity—backed by analytical data—remains a cornerstone of good scientific practice. I have seen too many projects delayed by inconsistencies in supplied material, underlining the need for careful vendor qualification and comprehensive analytical verification. Labs running high-sensitivity applications routinely check NMR, mass spectrometry, and elemental analysis to confirm batch identity and exclusion of trace contaminants. Those who skip this stage often revisit their results at costlier stages of development.
Faith in process integrity also leans heavily on traceable records. Good laboratory practice extends beyond note-taking: it sets a foundation for reproducibility and peer review. Sharing both successes and setbacks keeps the scientific community moving forward, reducing the risk that someone might repeat old mistakes with a molecule as nuanced as this one.
Progress in chemical synthesis depends both on the old ways and on taking smart risks. While 4-Bromo-3-(Trifluoromethyl)Aniline built a reputation from classic coupling reactions, new generations of chemists drive innovation using flow chemistry systems, greener solvents, and catalytic shortcuts. Some teams already report smaller environmental footprints by swapping hazardous reagents for milder, recyclable alternatives or using engineered biocatalysts for select functional group installation. These efforts not only reduce waste but prove that long-term sustainability and specialty chemicals can grow together.
As computational chemistry and machine learning take over more early-stage screening, compounds like 4-Bromo-3-(Trifluoromethyl)Aniline stand to gain new ground. Predictive algorithms now help narrow down which analogs will show improved activity or reduce toxicity, guiding synthesis priorities before a single round-bottom flask gets heated. My own transition from the bench towards integrating digital tools revealed a steep learning curve at first, but the value in catching weak leads early and saving resources made every challenge worthwhile.
Global demand for performance materials also shifts how specialty molecules get used. Sectors like battery technology, electronics, and advanced coatings push the need for robust building blocks that handle high voltage, resist chemical corrosion, and maintain stability in demanding environments. Looking out over the next decade, the same qualities that won 4-Bromo-3-(Trifluoromethyl)Aniline respect in pharma could build its legacy in clean energy and electronics.
Most substituted anilines run within similar territory, but the dual presence of bromine and trifluoromethyl sets this molecule apart. From firsthand observations layering it against analogs in small-scale screens, there’s little overlap in how it balances steric load and electronic pull. Medically, this means better odds of finding a lead compound resistant to metabolic deactivation, while preserving activity where many related structures fall short. In modern chemistry, the difference between a successful candidate and a missed opportunity often comes down to one group’s presence or absence.
Its attributes come at an increased cost and complexity. Not every project justifies using a high-value intermediate, and labs facing tight budgets may weigh up cheaper routes or structural close-relatives. Still, the tuneable features and proven track record explain why those aiming for ambitious results keep 4-Bromo-3-(Trifluoromethyl)Aniline in their toolkit rather than reach for less versatile substitutes.
The growing interdisciplinary nature of research work encourages greater transparency, collaboration, and communication. A molecule like 4-Bromo-3-(Trifluoromethyl)Aniline does not succeed alone; its story grows through interactions between synthetic chemists, analytical experts, safety officers, and regulatory advisors. Balancing purity, safety, and application value takes honest exchange and a willingness to share technical advances.
Drawing from years of lab work, one constant appears: researchers working closely across specialties unlock better outcomes. Analytical specialists tighten quality, reducing the risk of impurity interference in sensitive tests. Process engineers catch scale-up challenges long before pilot plants waste time and resources. Safety experts drive rigorous protocols, so no shortcut puts teams at risk. Regulatory advisors stay ahead of compliance hurdles, lighting the way for smoother tech transfer and market approvals.
In my experience, these cross-functional projects not only push each molecule further but speed up translation from lab to market. No single role replaces another; the best outcomes touch every bench and desk.
The journey of 4-Bromo-3-(Trifluoromethyl)Aniline from concept to application depends on more than technical know-how. Guiding principles—transparency, safety, environmental care, and open communication—serve as the backbone of trustworthy science. The compound’s adoption for new therapeutics, materials, or imaging agents speaks to both its chemical strengths and the commitment of those guiding it through each stage.
New solutions often emerge where respect for both science and the environment align. Chemists investing in cleaner synthesis methods, companies backing life-cycle analysis, and institutions prioritizing safe handling all set a higher bar for what specialty chemistry can deliver. Regulations and guidelines may evolve, but the core drive towards safer, more effective, and environmentally responsible chemistry remains steady.
The ongoing dialogue among researchers, environmental advocates, policy makers, and end-users keeps the entire system agile. Improvements in waste management, adoption of green chemistry, and expanded education in handling specialty chemicals reduce the risks and maximize the benefits of compounds like 4-Bromo-3-(Trifluoromethyl)Aniline. In this cycle of innovation and feedback, the molecule’s value extends far beyond any single discovery.
Every specialty molecule means more than its chemical formula. 4-Bromo-3-(Trifluoromethyl)Aniline shines for the doors it opens in challenging projects, blending robust reactivity with fine control over molecular properties. Its story tells of clever synthesis, cross-disciplinary teamwork, and the patient effort behind each successful new application.
Drawing from daily lab routines, troubleshooting setbacks, and shared discoveries, it’s clear that no molecule earns its place easily. Advances in pharmaceuticals, materials, and environmentally conscious production keep driving demand for such versatile intermediates. The future for 4-Bromo-3-(Trifluoromethyl)Aniline builds not just on chemistry, but on a scientific community willing to work together, share knowledge, and pursue the next leap forward with accountability and care.
